.
@BenClickMD
explains important findings from a recent study of nonalcoholic fatty liver disease in patients with both Crohn's and ulcerative colitis:
#DDW19
WRAP-IT trial demonstrates 40% relative reduction in major CIED infections with antibiotic-eluting envelope for cardiac devices versus standard infection prevention.
#ACC19
New research studies safety of immunotherapy in patients with myelodysplastic syndrome who either failed or never received conventional therapy.
#ASH18
Endoscopic submucosal dissection (ESD) has been offered since 2013 as an alternative to traditional surgery for early-stage gastric/esophageal tumors.
#DDW19
WRAP-IT trial shows placement of cardiac implantable electronic devices inside an antibiotic-eluting envelope reduced the incidence of major infections by 40% relative to standard prevention strategies.
#ACC19
Right-sided colorectal cancer (CRC) traditionally is characterized by DNA hypermethylation and high microsatellite instability (MSI), while left-sided CRC has been defined predominantly by chromosomal instability (CIN).
#ASCRS19
An oncologist argues that cancer patients whose clinical trial participation helps commercialize new therapies shouldn't have to pay once a trial ends: